Skip to main content
. Author manuscript; available in PMC: 2014 Nov 15.
Published in final edited form as: Transplantation. 2013 Nov 15;96(9):807–813. doi: 10.1097/TP.0b013e3182a0f668

Figure 2.

Figure 2

Kaplan-Meier estimates of patient survival according to ESA response comparing 3 months (A) to 6 months (B) of persistent ESA hyporesponsiveness. The probability of survival was lower in the ESA hyporesponsive group for both 3 and 6 months periods (Log-Rank p <0.01).